Accretion Nutraveda IPO Bidding Ends Today — Subscription & GMP Update

Accretion Nutraveda Ltd.’s SME IPO is in its **final day of subscription on 30 January 2026, with mixed investor response and muted sentiment in the grey market. The company is raising funds primarily for capacity expansion and operational scaling.

📌 IPO Key Dates & Pricing

IPO Opened: 28 January 2026
IPO Closes: 30 January 2026 (today)
Price Band: ₹122 to ₹129 per share
Allotment Date: 2 February 2026
Shares Credited/Refunds: 3 February 2026
Tentative Listing Date: 4 February 2026 on BSE SME platform

Accretion Nutraveda IPO

💰 Issue Size & Structure

The IPO consists entirely of a fresh issue of about 19 lakh shares.
Total capital to be raised: approximately ₹24.77 crore.

📊 Subscription Status (Day 3)

As the bidding period nears its end:

Overall subscription: about 1.83× the issue size.
Retail portion: 2.19× subscribed.
Non-Institutional Investors: 2.08× subscribed.
Qualified Institutional Buyers (QIBs): 1.01× subscribed.

Accretion Nutraveda IPO

📈 Grey Market & Listing Expectations

Grey Market Premium (GMP): ₹0 as of 30 January 2026, indicating no expected listing premium over IPO price.
This suggests that the stock might debut close to the upper end of the price band — ₹129 per share on listing day.

📌 Lot Size & Minimum Investment

Lot Size: 2,000 shares per lot (equivalent to a minimum investment of ₹2.58 lakh).

🧾 Use of Proceeds

The company plans to deploy the IPO funds mainly for:

Capacity expansion and automation — including machinery purchases.
New manufacturing setup investments.
Working capital requirements.
General corporate purposes.

🏢 About Accretion Nutraveda

Accretion Nutraveda is engaged in the production of Ayurvedic and nutraceutical products across various dosage forms such as tablets, capsules, liquids, powders, oils, creams, and gels. The company also operates as a contract development and manufacturing organization (CDMO) serving domestic and international markets including Sri Lanka, Singapore, and the US.